ARCHIVES

Sanofi: Zaltrap Price Reflects Competing Drugs In Second-Line Metastatic Colon Cancer

This article is from The Cancer Letter archive.

Vol. 38 No. 41 | November 1, 2012

Download PDF Visit The Full Archive

Related Articles

Pharmacia Letter Announces Suspension Of Two Trials.

May 11, 2001

Klausner Urges Emphasis On Research, Warns Against Shift To Health Programs.

December 15, 2000

Public Participation Hearings Develop Gals for Reducing Cancer Mortality

February 17, 1989

Timothy Talbot, Fox Chase Founder, Centers Advocate, Dies At Age 72

November 11, 1988

Research Contract Dollars Will Drop In 1980, But Will Increase Sharply for Some Programs

July 7, 1978

ADT May Increase Risk Of Cardio Events In Prostate Cancer Patients

February 5, 2010